Posterior hippocampal sparing in Lewy body disorders with Alzheimer's copathology: An in vivo MRI study
Jesse S Cohen1, Jeffrey Phillips2, Sandhitsu R Das2
1Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Neurology, University of Florida, Jacksonville, FL, USA.
Background:
Lewy body disorders (LBD), encompassing Parkinson disease (PD), PD dementia (PDD), and dementia with Lewy bodies (DLB), are characterized by alpha-synuclein pathology but often are accompanied by Alzheimer's disease (AD) neuropathological change (ADNC). The medial temporal lobe (MTL) is a primary locus of tau accumulation and associated neurodegeneration in AD. However, it is unclear the extent to which AD copathology in LBD (LBD/AD+) contributes to MTL-specific patterns of degeneration. We employ a MTL subregional segmentation strategy of T1-weighted (T1w) MRI in biomarker-supported or autopsy-confirmed LBD and LBD/AD+ to investigate the anatomic consequences of co-occurring LBD/AD+ pathology on neurodegeneration.
Methods:
We studied 167 individuals with clinical diagnoses of LBD (PD, n = 124 (74.3 %); PDD, n = 11 (6.6 %); DLB, n = 32 (19.2 %)) with available T1w MRI and AD biomarkers or autopsy evidence of ADNC. Individuals were further biologically classified as LBD/AD+ based on hierarchical evidence of ADNC pathology: 1) AD "intermediate" or "high" by ABC neuropathologic criteria (n = 39 (23.4 %)); 2) positive amyloid PET (n = 2 (1.2 %)); or 3) CSF β-amyloid1-42 < 185.7 pg/mL n = 126 (75.4 %)). The T1 Automated Segmentation of Hippocampal Subfields (ASHS) pipeline was used to compute volume and thickness measurements of MTL subregions in LBD/AD- and LBD/AD+. Linear regression tested the association of AD copathology and subregion volume/thickness, covarying for age and sex, and intracranial volume for volume measurements. Secondary analyses correlated MTL subregional volume/thickness with cognition and neuropathology.
Results:
LBD/AD+ had decreased volume/thickness compared to LBD/AD- in all MTL subregions except posterior hippocampus. The greatest effect sizes were seen in Brodmann Area 35 (BA35) (Cohen's d = 0.62, p = 0.002, β = 0.107 ± 0.034), and entorhinal cortex (ERC) (Cohen's d = 0.56, p = 0.006, β = 0.088 ± 0.031). Smaller differences were seen in the parahippocampal cortex (PHC) (Cohen's d = 0.5, p = 0.012, β = 0.082 ± 0.033), BA36 (Cohen's d = 0.47, p = 0.021, β = 0.090 ± 0.039) and anterior hippocampus (Cohen's d = 0.45, p = 0.029, β = 111.790 ± 50.595). Verbal memory scores positively correlated with volume/thickness in anterior and posterior hippocampus, BA35, ERC and PHC, while visuospatial memory positively correlated only in BA35. In the subset of participants with autopsy, lower ERC volume was associated with a higher tau load in ERC (adjusted odds ratio 0.013, 95 % CI [0.0002, 0.841], uncorrected p = 0.041).
Conclusions:
Relative to LBD/AD-, LBD/AD+ has greater T1w MRI evidence of atrophy in multiple MTL subregions. Atrophy in MTL subregions associates with memory performance and tau pathological load. The observed pattern of atrophy largely follows expectation from AD Braak stages, except for posterior hippocampus. Longitudinal studies are needed to validate the hypothesized spread of neurodegeneration.
Insights
Lewy body disorders (LBD) with Alzheimer's disease copathology (LBD/AD+) show greater medial temporal lobe atrophy than LBD alone. This atrophy correlates with memory deficits and tau pathology, particularly in specific regions like Brodmann Area 35.
Area of Science:
- Neuroimaging
- Neuropathology
- Neurodegeneration
Background:
- Lewy body disorders (LBD) feature alpha-synuclein pathology but often co-occur with Alzheimer's disease neuropathological changes (ADNC).
- The medial temporal lobe (MTL) is crucial in AD, but the impact of AD copathology on MTL degeneration in LBD remains unclear.
- Investigating MTL subregional atrophy in LBD with and without AD copathology (LBD/AD+) is essential.
Purpose of the Study:
- To investigate the anatomical consequences of co-occurring LBD/AD+ pathology on MTL neurodegeneration.
- To compare MTL subregional atrophy patterns between LBD/AD+ and LBD/AD- individuals using T1w MRI.
- To explore the relationship between MTL atrophy, cognition, and neuropathology.
Main Methods:
- Studied 167 individuals with LBD (PD, PDD, DLB) using T1w MRI and AD biomarkers or autopsy evidence of ADNC.
- Classified individuals into LBD/AD+ and LBD/AD- groups based on ADNC evidence (neuropathologic criteria, amyloid PET, CSF β-amyloid).
- Utilized the ASHS pipeline for MTL subregion volume/thickness measurements and linear regression to assess associations.
Main Results:
- LBD/AD+ individuals exhibited decreased MTL subregion volume/thickness compared to LBD/AD-, notably in Brodmann Area 35 (BA35) and entorhinal cortex (ERC).
- Significant correlations were found between verbal memory and MTL subregion volumes (hippocampus, BA35, ERC, PHC), and visuospatial memory with BA35 volume.
- Autopsy data revealed lower ERC volume associated with higher ERC tau load.
Conclusions:
- LBD/AD+ demonstrates greater T1w MRI-evidenced atrophy in multiple MTL subregions compared to LBD/AD-.
- MTL subregional atrophy is linked to memory performance and tau pathology, largely aligning with AD Braak stages except for the posterior hippocampus.
- Further longitudinal studies are required to confirm the hypothesized spread of neurodegeneration.
More Related Videos
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
Role of Hippocampus in Memory
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Overview
